Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-00-008455
Filing Date
2000-09-12
Accepted
2000-09-12 00:00:00
Documents
1
Group Members
JOHNSON & JOHNSONJOHNSON & JOHNSON DEVELOPMENT CORPORATION

Document Format Files

Seq Description Document Type Size
1 FINAL AMENDMENT TO SCHEDULE 13D y40325sc13da.txt SC 13D/A 16991
  Complete submission text file 0000950123-00-008455.txt   19236
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 9085240400
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42168 | Film No.: 721229
SIC: 2834 Pharmaceutical Preparations